Texas Cannabis Sales

Among small-tier U.S. cannabis markets, Texas posted one of the sharpest year-over-year jumps at 105.3%, driven by patient growth across just 13 dispensaries. The two-year gain of 32.1% is notable given the state's restrictive licensing framework, though falling prices suggest that supply is beginning to outpace demand within the narrow patient pool. Store count expanded 18.2% year over year, a meaningful increase for a market where new dispensary openings require legislative or regulatory action.

24-Month Trend

State	Sales	YoY
Locked State	$XX-XXM	XX.X%
Hawaii	$2.5-5M	9.9%
Locked State	$XX-XXM	XX.X%
Kentucky	$1-2.5M	990.4%
Locked State	$XX-XXM	XX.X%

Unlock The Full Table

Log in to unlock the full market comparison table and image export for this section.

Log in to unlockOpen app

Benchmarking

Market ComparisonAug 2026

Among small-tier U.S. cannabis markets, Texas posted one of the sharpest year-over-year jumps at 105.3%, driven by patient growth across just 13 dispensaries. The two-year gain of 32.1% is notable given the state's restrictive licensing framework, though falling prices suggest that supply is beginning to outpace demand within the narrow patient pool. Store count expanded 18.2% year over year, a meaningful increase for a market where new dispensary openings require legislative or regulatory action.

24-Month Trend

State	Sales	YoY
South Dakota	$5-10M	-4.8%
Hawaii	$2.5-5M	-9.9%
Texas	$2.5-5M	-8.4%
Kentucky	$1-2.5M	+990.4%
North Dakota	$1-2.5M	+12.9%

Top performing dispensaries in Texas.

Store	City	Est. Sales
#1 Fluent - Schulenburg	Schulenburg	<$250K

Topicals exploded at 447.2% year-over-year growth, the fastest-moving category in the Texas market, though they still account for only 5.1% of total share. Edibles hold the largest slice at 52.6%, doubling year over year, while oral products—at 42.2% share and 137.8% growth—are gaining ground quickly under Texas Original's product lineup. Concentrates disappeared entirely from tracked sales, falling 100% year over year, leaving the market almost exclusively split between ingestible formats as patients gravitate toward edibles and tinctures within the state's low-THC framework.

Category	Sales	Avg Price	YoY
#1Edibles	$1-2.5M	$27.5	45.7%
#2Vapes	$.5M-1M	$45.97	1734.8%
#3Oral	$.5M-1M	$73.98	15.9%
#4Concentrates	<$250K	$45.32	636.2%
#5Topicals	<$250K	$25.28	62.9%
#6Flower	<$250K	$51.99	9.5%
#7Accessories	<$250K	$10.68	43.1%
#8Pre-Rolls	<$250K	$15	73.7%